Who is sponsoring NCT04654858?

NCT04654858 is sponsored by Amal Ahmed Mohamed El Kot.

What drugs are being tested in NCT04654858?

Interventions in NCT04654858: Direct composite restorations.

What condition does NCT04654858 study?

NCT04654858 studies Molar Incisor Hypomineralization.

Is NCT04654858 still recruiting?

NCT04654858 is currently completed. Last updated 6 February 2024.

Last reviewed 2024-02-06 · How we verify

NCT04654858

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Restoration of Permanent Molars Affected With (MIH) Using Composite Restorations or Preformed Metal Crowns

Completed NA Last updated 6 February 2024

What this trial tests

NA trial testing Direct composite restorations in Molar Incisor Hypomineralization in 60 participants. Completed in 5 November 2023.

Timeline

4 July 2021

Primary endpoint
3 September 2023

5 November 2023

Quick facts

Lead sponsor	Amal Ahmed Mohamed El Kot
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	60
Start date	4 July 2021
Primary completion	3 September 2023
Estimated completion	5 November 2023
Sites	1 location across Egypt

Drugs / interventions tested

Direct composite restorations

Conditions studied

Molar Incisor Hypomineralization — all drugs for Molar Incisor Hypomineralization →

Sponsor

Amal Ahmed Mohamed El Kot

Who can join

Adults 7 to 12, any sex, with Molar Incisor Hypomineralization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the clinical outcome of using direct esthetic composite restorations in managing MIH cases and the use of preformed metal crowns.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Molar Incisor Hypomineralization

Currently open trials in the same condition.

NCT07389148 — Salivary Cortisol Levels in Children With Molar Incisor Hypomineralization · recruiting
NCT07469124 — Clinical Evaluation of Resin Infiltration Treatment of MIH-affected Teeth in Pediatric Patients · NA · active not recruiting
NCT07352813 — Intraosseous vs Infiltration Anesthesia in Molar-Incisor Hypomineralization (MIH) Children · NA · recruiting
NCT06776471 — Clinical Evaluation of Two Different Pit and Fissure Sealants · NA · recruiting
NCT06362681 — Effects of Different Remineralization Agents on Molar Incisor Hypomineralization Defects: a Randomized Clinical Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04654858 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Amal Ahmed Mohamed El Kot
Last refreshed: 6 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04654858.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing